[Molecular aspects of head and neck, and lung cancer oncogenesis]

Y Loriot1, P Mordant, P Fouret

  • 1Département de Médecine, Institut Gustave-Roussy, 39 Rue Camille-Desmoulins, 94800 Villejuif Cedex, France.

Bulletin Du Cancer
|May 13, 2009
PubMed

Insights

Lung and head and neck cancers arise from multistep genetic changes, influenced by tobacco carcinogens. Understanding these molecular alterations aids in developing targeted therapies for cancer prevention and treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Carcinogenesis

Background:

  • Lung and head and neck cancers develop through a multistep process involving oncogene activation and tumor suppressor gene inactivation.
  • These cancers share common molecular pathways and are linked to tobacco carcinogen exposure.
  • Molecular abnormalities characteristic of these cancers can be detected in pre-malignant lesions and normal tissues.

Purpose of the Study:

  • To explore the shared molecular basis of lung and head and neck carcinogenesis.
  • To identify molecular alterations that can be targeted for therapeutic intervention.
  • To evaluate the potential for molecular targeted agents in curative and chemopreventive strategies.

Main Methods:

  • Analysis of molecular abnormalities in cancer development.
  • Comparison of molecular players in lung and head and neck carcinogenesis.
  • Investigation of molecular alterations in pre-malignant and normal tissues.

Main Results:

  • Identified common molecular features and players in lung and head and neck cancer development.
  • Confirmed the role of tobacco carcinogens in initiating these multi-step processes.
  • Demonstrated the presence of molecular alterations in pre-malignant and normal tissues, suggesting early events in carcinogenesis.

Conclusions:

  • Knowledge of molecular carcinogenesis provides a basis for selecting targeted therapeutic strategies.
  • Molecular targeted agents hold promise for both treating and preventing lung and head and neck cancers.
  • Early detection of molecular alterations in pre-malignant lesions could inform targeted chemoprevention.

Related Concept Videos

Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...